<?xml version="1.0" encoding="UTF-8"?>
<svg height="892.515" width="587.4136063533333" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 12 of 27</text>
  <text x="40.769,47.167,51.429,56.764,60.672,64.408,68.143,71.879" y="31.187000000000012" svg_rhmargin="74.273" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.58px;font-style:ITALIC;font-weight:normal;">Cancers </text>
  <text x="74.249,79.073,83.898,88.722" y="31.187000000000012" svg_rhmargin="93.51" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.58px;font-style:NORMAL;font-weight:bold;">2018</text>
  <text x="93.545,95.92" y="31.187000000000012" svg_rhmargin="98.314" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.58px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="98.296,103.121" y="31.187000000000012" svg_rhmargin="107.909" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.58px;font-style:ITALIC;font-weight:normal;">10</text>
  <text x="107.944,110.342,112.718,117.663,120.057,543.76,548.583,550.959,556.222,559.389,561.765,566.588,571.41" y="31.187000000000012" svg_rhmargin="573.804" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.58px;font-style:NORMAL;font-weight:normal;">, x 3 of 29 </text>
  <text style="fill:#000000;font-family:IKMAII+TimesNewRoman;font-size:10.8px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="43.469" y="599.987" x=""/>
  <text y="599.987" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="505.655" x=""/>
  <text x="66.257,72.285,75.882,81.888,88.488,92.69,98.091,100.791,101.691,107.092" y="619.571" svg_rhmargin="109.792" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">Figure 2.</text>
  <text y="619.571" svg_rhmargin="338.972" x="113.417,120.046,126.34,131.522,134.22199999999998,135.05,138.579,144.484,148.759,153.94,158.528,162.058,164.75799999999998,165.657,172.157,175.308,181.214,184.668,189.255,191.95499999999998,192.855,198.76,202.365,205.065,205.894,215.4,220.584,224.113,229.522,233.127,238.536,244.83,250.239,253.39,259.365,263.952,267.104,271.692,274.392,275.22,280.629,286.61,292.515,298.995,302.525,305.22499999999997,306.124,314.622,321.845,329.068,331.776,334.476,335.376" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-analysis about ORR: (</text>
  <text x="338.921" y="619.571" svg_rhmargin="344.321" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">a</text>
  <text x="344.321,347.876,350.57599999999996,351.476,357.439,363.345,367.57,372.754,377.363,380.889,383.589,384.489,390.968,394.136,400.041,403.567,406.267,407.167,410.722,416.628,420.853,423.553,424.452,432.947,440.147" y="619.571" svg_rhmargin="447.361" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.8px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="450.053" y="619.571" x=""/>
  <text x="450.952,456.366,462.666,469.279,471.979,472.878,480.55,484.203,486.90299999999996,487.732,490.828,497.092,499.792,500.692,505.285,511.196,514.353,517.449,524.062,526.7620000000001,527.661,533.076,539.375,545.988" y="619.571" svg_rhmargin="548.688" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">and CI in solid and </text>
  <text x="66.256,72.531,77.694,87.219,92.608,96.118,102.004,105.172,111.077,117.071,120.239" y="635.123" svg_rhmargin="125.034" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">hematologic</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.8px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="127.781" y="635.123" x=""/>
  <text x="128.537,137.97,143.37,146.522,149.673,155.648,161.942,167.351,173.645,178.449,181.6,186.782,191.32,194.01999999999998,194.776,201.276,206.684,210.138,213.306,218.488,224.782,228.311,232.899,235.599,236.283,242.188,245.793,248.493,249.177,254.359,259.768,264.571,270.866,273.566,274.249,278.837,282.291,288.771,295.397,301.371,304.07099999999997,304.827,310.236,316.53,323.138,325.83799999999997,326.594,330.123,336.417,341.529,344.229,344.985,350.818,356.938,362.12,366.395,371.804,374.955,378.106,380.771,383.471,384.227" y="635.123" svg_rhmargin="387.823" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">malignancies patients of each study and the overall; (</text>
  <text x="387.664" y="635.123" svg_rhmargin="394.263" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">b</text>
  <text x="394.288,397.879,400.579,401.335,407.334,413.226,417.486,422.654,427.228,430.743,433.443,434.199,440.685,443.822,449.714,453.229,455.929,456.685,460.276,466.167,470.428,473.128,473.884,482.367,489.495,496.704,499.404,500.16,505.555,511.835,518.429,521.129,521.885,529.445,533.118,535.8180000000001,536.501,539.639,545.974" y="635.123" svg_rhmargin="548.674" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR and CI in </text>
  <text x="66.256,72.867,76.022,79.63,83.238,88.423,92.701,97.886,104.184,107.716,110.381,116.991,120.6,125.407,130.518,133.673" y="650.819" svg_rhmargin="136.816" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">different B-cell</text>
  <text y="650.819" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.8px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="139.516" x=""/>
  <text x="139.48,148.986,154.386,157.541,160.696,166.67,172.968,178.38,184.677,189.484,192.639,197.824,202.415,205.151,211.559,216.958,220.491,223.646,228.831,235.128,238.661,243.252,245.988,251.896,255.425,258.16,263.346,268.673,273.48,279.778,282.442,287.033,290.566,297.046,303.672,309.646,312.382,317.794,324.091,330.702,333.438,336.97,343.268,348.379,351.044,356.952,363.066,368.251,372.529,377.941,381.096,384.25,386.915" y="650.819" svg_rhmargin="389.615" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">malignancies patients of each study and the overall. </text>
  <text x="40.769,46.773,49.771,55.774,58.772,61.724,73.066,77.735,81.73,87.061,91.056,99.729,106.406,111.664,114.998,121.002,125.671,129.005,133.674,136.698,142.028,145.363,148.387,156.398,164.41,172.421,175.445,180.776,184.11,187.134,195.146,203.818,211.83,214.854,222.192,225.144,232.483,238.486,243.155,247.824,253.082,259.146,265.147,268.171,271.503,278.177,281.201,288.537,293.795,297.788,301.12,305.787,312.461,316.454,321.121,324.073,332.743,336.075,340.068,346.07,349.094,358.437,361.769,365.101,368.433,373.1,377.766,382.433,389.107,393.1,396.052,407.392,412.72,416.052,419.383,425.385,432.059,437.387,444.062,448.944,452.276,456.943,461.609" y="681.059" svg_rhmargin="464.615" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">2.4. Meta-Analysis of CRR of CAR T Therapy in Patients with Different Malignancies </text>
  <text x="66.258,72.922,79.465,84.193,88.091,94.755,98.786,105.763,109.291,116.267,122.005,125.011,126.181,131.257,135.071,142.3,149.625,153.153,158.84,163.917,166.923,168.093,172.075,178.065,184.113,190.104,196.094,202.142,205.127,211.175,217.165,223.155,229.203,235.194,238.178,244.168,250.159,256.207,262.197,268.245,271.23,277.22,283.268,289.259,295.249,301.297,305.329,308.335,309.432,312.96,319.944,325.261,328.697,335.957,343.232,346.688,353.671,360.366,363.37199999999996,364.542,370.518,376.566,382.542,385.54799999999994,386.718,393.954,399.975,403.862,407.389,413.159,420.07,423.956,429.07,432.07599999999996,433.246,443.283,449.053,453.812,459.581,462.587,463.757,469.444,472.953,476.461,483.083,486.591,493.141,496.649,502.419,505.42499999999995,506.595,510.608,517.089,521.848,524.8539999999999,526.024,529.91,536.894,542.663,545.669,546.839,555.373,563.366,571.407" y="704.4590000000001" svg_rhmargin="574.413" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">Forty-nine studies [14–19,21–32,34–55,57–65] including 841 patients were eligible for the CRR </text>
  <text x="40.769,46.51,53.284,59.332,62.788,70.019,76.067,79.968,83.447,89.993,96.972,100.068,106.614,110.646,113.67,122.175,131.511,139.575,142.672,150.023,153.119,157.02,163.999,169.739,174.469,180.462,187.669,194.335,197.431,200.959,207.943,211.039,218.246,224.294,228.195,231.674,237.415,244.393,248.294,253.373,256.469,266.478,270.006,273.906,280.885,283.981,291.309,294.788,298.82,302.852,308.538,313.218,318.977,325.888,329.775,332.871,343.501,349.526,353.039,356.494,363.193,370.204,376.229,383.241,388.499,392.027,397.715,402.829,405.848,408.944,416.328,423.339,429.112,432.208,440.747,448.739,456.784,459.808,463.32,470.232,473.328,479.101,485.126,490.478,497.489,500.585,505.843,509.355,512.868,519.779,523.291,528.643,534.619,538.147,541.171,546.282,550.169,557.432,564.792,571.491" y="720.587" svg_rhmargin="574.497" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">evaluation of CAR T therapy in patients with different malignancies. The CRR in each clinical study </text>
  <text x="40.769,47.749,53.743,61.072,63.807,73.817,77.298,84.627,90.368,93.104,100.432,103.913,107.899,111.885,117.627,122.358,128.1,135.08,140.4,146.142" y="736.787" svg_rhmargin="151.24" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">had wide differences</text>
  <text y="736.787" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="154.223" x=""/>
  <text x="153.952,159.94,165.015,167.751,177.755,183.491,187.018,190.474,193.211,197.191,201.222,205.948,212.489,223.003,225.739,231.727,234.709,240.757,250.767,253.432,257.328,263.869,266.605,272.593,278.641,284.629,287.611,293.659,303.669,307.701,310.653,313.389,320.736,327.71,333.446,336.182,342.723,349.493,355.228,359.872,365.92,369.382,372.843,375.579,381.301,386.362,390.245,393.706,404.286,410.334,414.217,419.939,422.674,429.202,433.234,435.969,444.393,452.386,460.45,463.115,469.163,476.146,483.456,486.191,492.166,498.214,508.277,511.012,519.5,523.515,526.179,530.211,534.891,541.419,551.999,554.734,558.617,565.577,571.299" y="736.787" svg_rhmargin="574.305" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">as well (from 0.0% to 100.0%). The overall estimate of CRR and 95% CI from the </text>
  <text x="40.768,44.277,51.284,58.641,62.149,68.845,72.373,79.73,86.929,92.951,96.407,99.413,101.59,106.698,110.512,117.772,125.129,128.637,134.325,139.432,142.438,144.616,154.654,160.423,165.102,170.862,173.868,176.045,181.087,188.071,194.645,204.683,211.691,214.697,216.874,220.383,227.39,230.396,232.574,239.196,242.723,249.345,256.617,261.376,267.145,270.15099999999995,272.257,278.278,284.254,287.27,290.27599999999995,292.453,302.467,309.042,319.555,326.109,332.804,338.573,345.58,351.349,354.858,358.744,365.439,368.445,370.623,374.509,380.196,385.304,389.19,392.19599999999997,394.374,400.395,407.631,414.867,420.636,426.612,431.364,437.133,444.49,447.496,449.673,453.559,460.471,466.492,470.378,473.38399999999996,475.562,479.448,486.432,492.201,497.308,503.078,506.08399999999995,508.189,513.297,517.183,524.443,531.718,535.226,540.995,546.103,549.1089999999999,551.287,558.198,564.246,571.521" y="752.987" svg_rhmargin="574.527" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">individual studies were shown in Figure 3a. Homogeneity test appeared that these studies had </text>
  <text x="40.768,45.877,49.387,56.083,62.995,66.504,70.464,73.974,79.323,85.346,92.355,96.169,98.976,105.985,111.674,115.56,121.319,126.08,132.656,139.352,145.122,152.131,157.901,161.411,165.297,171.919,174.726,178.741" y="769.187" svg_rhmargin="182.793" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">significant heterogeneity (I</text>
  <text x="182.681" y="766.163" svg_rhmargin="186.281" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:7.2px;font-style:NORMAL;font-weight:normal;">2</text>
  <text y="769.187" svg_rhmargin="225.937" x="189.089,195.065,197.873,203.848,209.897,219.961,222.931" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">= 78%, </text>
  <text x="225.665" y="769.187" svg_rhmargin="231.677" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="769.187" svg_rhmargin="574.344" x="234.448,240.422,243.229,249.203,252.171,258.219,264.195,268.226,271.178,273.986,281.318,288.277,294.037,298.789,304.51,308.542,315.068,319.82,325.541,328.565,331.373,341.362,347.083,349.891,357.163,362.205,367.964,375.31,378.117,381.999,388.958,394.679,397.414,402.166,408.214,415.174,422.519,429.046,439.625,443.59,449.35,453.315,457.347,463.106,468.365,472.246,475.053,485.632,492.159,499.504,505.264,508.724,511.532,515.413,521.94,524.747,530.078,536.054,539.514,544.844,552.117,555.572,561.62,565.506,571.338" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">&lt; 0.01). Therefore, we used the random-effect model to calculate </text>
  <text x="40.769,44.669,51.646,57.385,67.982" y="785.387" svg_rhmargin="70.988" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">them.</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="74.016" y="785.387" x=""/>
  <text x="78.426,85.738,92.721,98.481,101.487,105.897,112.404,119.138,124.898,129.65,135.698,139.153,142.681,145.687,150.098,157.265,163.818,170.324,173.852,179.553,186.898,189.904,194.315,202.781,210.754,218.818,221.824,226.235,232.741,236.773,239.779,244.189,252.655,262.017,270.082,273.08799999999997,277.498,284.81,287.816,292.226,296.087,303.071,308.83,313.582,319.535,326.703,333.396,336.402,340.866,344.897,351.45,356.165,359.171,363.581,370.773,376.821,380.706,384.234,389.958,396.921,400.806,405.87,408.876,413.286,423.279,426.807,430.692,437.655,440.66099999999994,445.072,450.135,456.665,460.129,463.657,470.969,473.97499999999997,478.313,484.361,491.345,498.656,501.662,506.073,513.036,518.761,529.343,535.391,539.276,545.806,549.334,555.887,562.537,566.065,571.369" y="785.387" svg_rhmargin="574.375" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">The overall pooled CRR of CAR T therapy for patients with solid and hematologic </text>
  <text x="40.769,51.355,57.403,60.859,64.387,71.087,77.998,84.025,91.037,96.39,99.903,105.592,110.634,113.64,114.882,124.924,130.951,136.063,139.069,140.311,146.287,152.335,162.45,165.456,166.626,170.644,176.62,182.596,192.678,195.684,196.926,205.422,209.455,212.476,215.482,216.724,222.75,228.726,234.753,240.728,246.704,256.786,260.805,263.825,266.83099999999996,268.073,275.459,282.471,288.245,291.251,292.493,297.535,304.807,311.428,318.05,322.814,329.393,336.658,343.857,346.863,348.105,354.132,361.043,367.069,370.525,377.225,382.337,385.793,390.835,393.84099999999995,395.083,399.847,405.621,410.733,417.933,421.447,425.333,428.339,429.581,434.694,441.706,448.286,458.328,464.017,471.362,474.368,475.61,479.496,486.48,492.506,496.392,499.39799999999997,500.641,504.527,511.51,517.284,520.29,521.532,530.072,538.118,546.165,549.1709999999999,550.413,560.349,566.397,571.51" y="801.587" svg_rhmargin="574.516" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">malignancies was 42% (95% CI: 32–53%). The subgroup analysis result showed that the CRR was </text>
  <text x="40.769,45.872,49.376,56.066,62.978,66.481,70.441,73.945,79.288,85.305,92.308,96.122,99.65,106.34,109.508,116.511,120.015,126.705,133.708,139.472,144.152,147.392,151.401,157.971,162.651,165.891,173.122,179.139,182.953,186.481,192.245,199.248,203.134,208.248,211.489,221.425,224.953,228.839,235.823,239.063,246.066,251.753,262.375,268.392,272.278,278.831,282.335,288.905,295.527,299.055,304.398,307.638,318.152,324.128,327.632,331.136,337.826,344.737,350.785,357.788,363.046,366.55,372.314,377.356,380.597,384.556,390.604,396.58,406.662,409.673,412.841,418.858,424.875,434.885,438.125,446.655,450.712,453.723,456.891,462.867,468.843,474.891,480.867,486.915,496.925,500.957,504.197,509.541,516.111,526.733,533.964,539.94,544.692,550.456,557.807,561.048,564.934,571.415" y="817.787" svg_rhmargin="574.421" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">significantly higher for patients with hematologic malignancies (60%, 95% CI: 48–70%) compared to </text>
  <text x="40.769,47.968,54.016,57.902,61.43,67.202,74.212,78.098,83.212,86.812,96.852,100.363,104.249,111.16,114.76,119.87,126.448,129.959,133.414,140.773,144.373,154.959,160.935,164.446,167.902,174.599,181.51,187.534,194.544,199.895,203.406,209.093,214.207,217.807,221.767,227.743,233.767,243.879,246.897,250.425,256.449,262.473,272.585,276.185,284.681,288.714,291.732,295.26,301.236,307.284,313.26,319.236,329.318,333.334,336.352,339.952,347.335,354.345,360.116,363.716,368.758,376.03,382.651,389.273,394.035,400.612,407.874,415.073,418.673,424.697,431.608,437.632,441.088,447.786,452.827,456.338,461.38,464.98,469.741,475.513,480.623,487.823,491.334,495.22,498.82,503.582,509.353,515.975,522.023,526.784,534.058,537.569,544.579,551.276,554.876,558.762,565.746,571.517" y="833.915" svg_rhmargin="574.523" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">patients with solid malignancies (11%, 95% CI: 7–19%). The subgroup analysis result regarding the </text>
  <text x="40.769,47.974,54.022,57.92,61.448,67.186,74.162,78.061,83.137,86.143,87.097,97.103,100.631,104.529,111.505,114.511,115.465,122.79,126.318,130.3,134.332,140.07,144.797,150.535,157.512,161.41,164.416,165.369,172.694,176.726,182.043,187.781,191.309,194.836,197.842,198.796,209.31,215.358,218.835,222.363,229.027,235.961,241.971,248.966,254.224,257.752,263.509,268.605,271.611,272.564,276.566,283.249,286.746,293.429,300.677,305.424,311.181,314.18699999999995,315.069,321.079,327.628,331.63,334.63599999999997,335.59,340.685,347.681,354.244,364.269,370.026,377.371,380.37699999999995,381.33,385.247,392.243,398.253,402.17,405.176,406.13,410.047,417.043" y="850.115" svg_rhmargin="422.802" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">patients with different B-cell malignancies (Figure 3b) showed that the</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="425.735" y="850.115" x=""/>
  <text x="426.688,435.191,443.256,451.321,454.327,455.28,461.823,465.855,468.861,469.744,476.948,482.997,486.895,490.423,496.16,503.137,507.035,512.112,515.1179999999999,516.071,526.077,529.605,533.503,540.48,543.486,544.439,553.772,561.097,568.422,571.407" y="850.115" svg_rhmargin="574.413" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">CRR of patients with ALL, </text>
  <text x="40.768,50.746,58.066,61.045,63.638,73.603,83.581,90.901,93.493,99.541,106.525,113.845,116.51,125.008,132.329,139.649,142.313,152.315,158.048,162.771,168.504,171.168,177.154,183.14,193.213,195.878,199.909,205.885,211.933,222.016,224.68,233.179,237.204,240.184,242.848,248.834,254.819,260.868,266.853,272.901,282.975,287.006,289.986,292.578,298.626,304.602,314.676,317.341,321.318,327.304,333.352,343.434,346.098,354.597,358.622,361.602,364.194,370.18,376.228,382.213,388.262,398.335,402.367,405.346,407.939,413.987,420.035,430.045,432.709,436.687,442.672,448.72,458.803,461.467,469.891,473.924,476.904,479.568,485.554,491.602,497.587,503.573,509.621,519.694,523.672,526.336,532.385,539.296,546.616,549.281,555.266,561.314,571.388" y="866.315" svg_rhmargin="574.394" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">HL, NHL and CLL were 76% (95% CI: 67–83%), 13% (95% CI: 1–72%), 35% (95% CI: 17–59%) and 48% </text>
  <text x="40.768,44.8,50.776,56.824,66.906,69.93,78.43,82.457,85.437,88.461,94.448,100.435,106.483,112.47,118.518,128.593,132.571,135.552,138.576,143.3,149.035,154.108,161.309,167.043,172.356,176.251,179.725,186.493,192.227,195.755,202.449,205.43" y="882.515" svg_rhmargin="208.436" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">(95% CI: 22–76%), respectively. </text>
  <rect style="stroke:blue;stroke-width:0.3;" x="109.529" y="48.468" height="551.52" width="393.12" title="12"/>
  <text x="109.529" y="48.468" class="image" id="image.12.1" width="393" height="551">image.12.1.110_503.48_600</text>
  <text svg_rhmargin="133.58" x="97.795,102.78,105.766,110.751,116.23,119.718,124.20100000000001,126.855,131.338,133.57999999999998" y="616.417" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Figure 2. </text>
  <text x="137.596,143.202,148.525,152.906,155.558,158.604,163.597,167.045,171.426,175.304,178.286,180.947,186.443,189.105,194.098,197.08,200.95800000000003,203.61,208.603,211.649,214.301,222.377,226.758,229.739,234.312,237.358,241.93,247.253,251.826,254.488,259.573,263.45,266.112,269.99,272.642,277.215,282.272,287.266,292.781,295.76300000000003,298.414,305.603,311.712,317.822,320.109,322.76" y="616.417" svg_rhmargin="325.806" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-analysis about ORR: (</text>
  <text x="325.808" y="616.417" svg_rhmargin="330.291" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">a</text>
  <text x="330.291,333.337,335.989,341.074,346.067,349.524,353.905,357.783,360.76500000000004,363.417,368.913,371.575,376.568,379.55,382.202,385.248,390.241,393.854,396.506,403.694,409.804,415.914,418.565,423.138,428.461,434.04900000000004,436.701,443.186,446.268,448.92,451.582,456.905,459.557,463.434,468.428,471.089,473.751,479.339,482.0,486.573,491.896" y="616.417" svg_rhmargin="497.484" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR and CI in solid and</text>
  <text x="97.795,103.118,107.499,115.574,120.147,123.129,128.122,130.784,135.777,140.862,143.524,147.585,150.072,158.148,162.721,165.382,168.043,173.128,178.451,183.024,188.347,192.408,195.069,199.45,203.32799999999997,205.806,211.303,215.875,218.857,221.518,225.899,231.222,234.203,238.08100000000002,240.569,245.562,248.608,251.087,255.467,260.04,264.101,269.424,271.911,275.789,278.771,284.285,289.874,294.959,297.446,302.019,307.342,312.93,315.408,318.39,323.713,328.09400000000005,330.581,335.575,340.742,345.123,348.735,353.308,355.97,358.631,360.91799999999995,363.524" y="629.239" svg_rhmargin="366.57" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">hematologic malignancies patients of each study and the overall; (</text>
  <text x="366.569" y="629.239" svg_rhmargin="372.047" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">b</text>
  <text x="372.048,375.094,377.581,382.666,387.66,391.108,395.488,399.366,402.348,404.835,410.332,412.993,417.987,420.96900000000005,423.447,426.492,431.486,435.099,437.586,444.775,450.884,456.994,459.481,464.054,469.377,474.96500000000003,477.443,483.928,487.01,489.497,492.159" y="629.239" svg_rhmargin="497.482" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR and CI in</text>
  <text x="97.795,103.273,105.883,108.707,111.693,115.988,119.368,123.663,128.882,131.805,134.046,139.525,142.51,146.492,150.786,153.396,156.005,158.246,166.164,170.647,173.256,175.865,180.851,186.069,190.552,195.771,199.752,202.361,206.656,210.458,212.699,218.088,222.571,225.494,228.104,232.399,237.617,240.54,244.34199999999998,246.583,251.479,254.465,256.707,261.001,265.485,269.466,274.684,276.926,280.728,283.651,289.057,294.536,299.521,301.763,306.246,311.464,316.942,319.184,322.107,327.326,331.62100000000004,333.862,338.758,343.824,348.119,351.661,356.144,358.753,361.362" y="642.061" svg_rhmargin="363.604" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">different B-cell malignancies patients of each study and the overall.</text>
  <text x="76.535,81.516,84.007,88.988,91.479,94.567,103.972,107.847,111.165,115.588,118.906,126.099,131.638,136.062,138.831,143.812,147.688,150.457,154.333,156.824,161.247,164.01700000000002,166.507,173.152,179.797,186.442,188.933,193.356,196.126,198.617,205.262,212.455,219.10000000000002,221.59,227.677,230.168,236.255,241.237,245.112,248.988,253.411,258.392,263.374,265.864,268.634,274.173,276.664,282.751,287.174,290.492,293.261,297.137,302.676,305.994,309.87,312.36,319.553,322.322,325.64,330.622,333.112,340.863,343.632,346.402,349.171,353.047,356.743,360.619,366.158,369.476,371.966,381.371,385.794,388.564,391.333,396.315,401.854,406.277,411.816,415.871,418.641,422.516" y="663.143" svg_rhmargin="426.391" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">2.4. Meta-Analysis of CRR of CAR T Therapy in Patients with Different Malignancies</text>
  <text x="97.795,103.445,108.993,113.007,116.32,121.97,125.354,131.268,134.225,140.139,145.007,148.025,152.334,155.646,161.774,167.983,170.94,175.807,180.11599999999999,183.144" y="682.63" svg_rhmargin="186.528" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">Forty-nine studies [</text>
  <text x="186.527,191.508" y="682.63" svg_rhmargin="196.489" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">14</text>
  <text x="196.49" y="682.63" svg_rhmargin="201.571" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="201.571,206.552" y="682.63" svg_rhmargin="211.533" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">19</text>
  <text x="211.533" y="682.63" svg_rhmargin="214.073" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="214.074,219.055" y="682.63" svg_rhmargin="224.036" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">21</text>
  <text x="224.037" y="682.63" svg_rhmargin="229.118" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="229.117,234.098" y="682.63" svg_rhmargin="239.079" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">32</text>
  <text x="239.08" y="682.63" svg_rhmargin="241.62" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="241.621,246.602" y="682.63" svg_rhmargin="251.583" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">34</text>
  <text x="251.583" y="682.63" svg_rhmargin="256.664" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="256.664,261.645" y="682.63" svg_rhmargin="266.626" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">55</text>
  <text x="266.627" y="682.63" svg_rhmargin="269.167" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="269.167,274.148" y="682.63" svg_rhmargin="279.129" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">57</text>
  <text x="279.13" y="682.63" svg_rhmargin="284.211" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="284.211,289.192" y="682.63" svg_rhmargin="294.173" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">65</text>
  <text x="294.174,297.558,300.576,303.533,309.447,313.959,316.916,323.044,329.253,332.21,338.124,343.774,346.802,351.883,356.964,362.045,365.063,371.17,376.251,379.564,382.521,387.389,393.303,396.616,400.925,403.952,412.427,417.295,421.126,425.99399999999997,429.022,433.889,436.846,439.803,445.453,448.411,454.03,456.987,461.855,464.873,468.257,473.805,477.819,480.837,484.15,490.064,494.932,497.96,505.164,511.953" y="682.63" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">] including 841 patients were eligible for the CRR</text>
  <text x="76.535,81.34,87.009,92.025,94.944,100.994,106.01,109.281,112.2,117.678,123.517,126.014,131.492,134.833,137.331,144.444,152.249,158.95,161.449,167.59900000000002,170.097,173.367,179.206,184.011,187.974,192.99,199.02,204.598,207.096,210.015,215.85399999999998,218.352,224.382,229.398,232.668,235.588,240.393,246.232,249.503,253.75699999999998,256.254,264.621,267.541,270.811,276.65,279.148,285.278,288.197,291.357,294.698,299.504,303.286,308.091,313.93,317.2,319.699,328.557,333.573,336.493,339.412,344.99,350.829,355.845,361.684,366.138,369.058,373.863,378.117,380.625,383.735,389.885,395.724,400.529,403.027,410.14,416.842,423.543,426.041,428.961,434.8,437.298,442.103,447.119,451.574,457.413,459.91,464.365,467.284,470.204,476.042,478.962,483.416,488.432,491.351,493.85,498.104,501.374,507.424,513.553" y="696.14" svg_rhmargin="519.131" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">evaluation of CAR T therapy in patients with different malignancies. The CRR in each clinical study</text>
  <text x="76.535,82.449,87.53,93.739,96.523,104.998,107.955,114.164,119.032,121.816,128.025,130.982,134.193,137.567,142.435,146.276,151.143,157.058,161.569,166.437,170.746,173.53,178.611,182.92,185.704,194.179,199.046,202.003,204.95999999999998,207.745,211.129,214.513,218.344,223.892,232.865,235.649,240.73,243.271,248.352,256.888,259.672,262.985,268.533,271.317,276.398,281.479,286.56,289.101,294.182,302.718,306.101,308.642,312.615,318.844,324.759,329.627,332.41,337.959,343.7,348.568,352.582,357.663,360.62,363.577,366.361,371.229,375.537,378.85,381.807,390.78,395.861,399.174,404.042,406.826,412.374,415.75800000000004,418.552,425.757,432.545,439.333,442.118,447.199,453.113,459.322,462.106,467.187,472.268,480.804,483.588,490.793,494.218,497.002,500.386,504.217,509.765" y="709.649" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">had wide differences as well (from 0.0% to 100.0%). The overall estimate of CRR and 95% CI from</text>
  <text x="76.535,79.848,85.762,90.63,93.16,96.117,102.031,108.24,111.197,116.939,119.896,126.105,132.232,137.313,140.26999999999998,142.811,147.119,150.432,156.56,162.768,165.726,170.593,174.902,177.432,185.907,190.775,194.606,199.474,202.014,206.322,212.236,217.785,226.26,232.17399999999998,234.704,237.661,243.575,246.106,251.756,254.713,260.363,266.491,270.332,275.2,277.73,282.81,287.891,290.432,293.653,302.108,307.656,316.629,322.177,327.827,332.695,338.609,343.477,346.434,349.747,355.397,357.927,361.24,366.107,370.416,373.729,376.259,381.34,387.447,393.554,398.422,403.503,407.344,412.211,418.42,420.951,424.263,430.178,435.259,438.572,441.112,444.425,450.339,455.196,459.505,464.373,466.913,471.221,474.534,480.662,486.871,489.828,494.695,499.004,501.534,507.448,512.529" y="723.158" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">the individual studies were shown in Figure 3a. Homogeneity test appeared that these studies had</text>
 </g>
</svg>
